BIRC5 and non-small cell lung carcinoma: The H-VAE-Cox and XAT-VAE-Cox models identified 24 and 51 genes associated with the NSCLC pathway, respectively, as shown in Figure 7B. The mutation of KRAS, EGFR, TRIM59, P53, cyclines, P16INK4, P14ARF, survivin, VEGF, and telomerase are considered potentially clinically useful as prognostic biomarkers and several studies have demonstrated their negative correlation with survival time.100